Case Study
Tay-Sachs Disease General
Healthy Metabolism
Altered Metabolism
100

How old is the patient? 

15 years old

100

How many different diagnoses are there?

3 (Infantile, Juvenile, and late-onset)

100

What is the key pathway?  

Lysosomal degradation of gangliosides 

100

What chromosome is the mutation in?

15q

200

What was she originally diagnosed with? 

Cavovarus Deformity 

200

What are the typical symptoms of Infantile? 

Mild motor weakness, irritability, and hypersensitivity to auditory and other sensory stimuli  

200

What is the key enzyme that catalyzes the removal of the N-acetylgalactosamine residue from GM2?

HexA (B-hexosaminidase A)

200

What ganglioside is there a buildup of?

GM2

300

Why was she taken off the miglustat treatment?

Due to muscle weakness, functional impairment, and changes in bowel habits

300

What are the typical symptoms of Juvenile?

Incoordination, clumsiness, and muscle weakness

300

What cofactor does this reaction require?

GM2A

300

The HexA enzyme cannot cleave from which terminal of the GM2 ganglioside?

GalNAc

400

How much weight did she lose? 

About 14 kg

400

When can symptoms start in someone with late-onset Tay-Sachs?

Late adolescence or early adulthood

400

What does this cofactor do?

Presents the GM2 to HEXA enzyme

400

What does the accumulation of GM2 lead to?

Autosomal swelling, impaired trafficking, and neurogeneration

500

What year was she referred to a dietitian? 

2018

500

What disease is Tay-Sachs characterized by?

Sphingolipidoses disorder